Niagen Bioscience, Inc.
NAGE
$9.89
-$0.15-1.49%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 60.32M | 55.46M | 44.51M | 32.25M | 27.73M |
| Total Receivables | 10.26M | 7.95M | 8.67M | 8.00M | 8.72M |
| Inventory | 14.41M | 11.19M | 9.19M | 10.54M | 11.51M |
| Prepaid Expenses | 1.54M | 1.47M | 1.58M | 1.20M | 1.19M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 152.00K | 152.00K | 152.00K | 152.00K | 152.00K |
| Total Current Assets | 86.68M | 76.22M | 64.10M | 52.13M | 49.30M |
|
|
|||||
| Total Current Assets | 86.68M | 76.22M | 64.10M | 52.13M | 49.30M |
| Net Property, Plant & Equipment | 4.16M | 4.34M | 3.45M | 3.62M | 3.90M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 284.00K | 322.00K | 359.00K | 397.00K | 435.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 405.00K | 458.00K | 368.00K | 374.00K | 394.00K |
| Total Assets | 91.53M | 81.34M | 68.28M | 56.52M | 54.04M |
|
|
|||||
| Total Accounts Payable | 13.68M | 10.63M | 8.53M | 6.90M | 8.11M |
| Total Accrued Expenses | 7.38M | 9.05M | 7.82M | 9.59M | 8.62M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 963.00K | 948.00K | 994.00K | 1.02M | 985.00K |
| Total Finance Division Other Current Liabilities | 303.00K | 207.00K | 611.00K | 184.00K | 156.00K |
| Total Other Current Liabilities | 303.00K | 207.00K | 611.00K | 184.00K | 156.00K |
| Total Current Liabilities | 22.33M | 20.84M | 17.95M | 17.70M | 17.87M |
|
|
|||||
| Total Current Liabilities | 22.33M | 20.84M | 17.95M | 17.70M | 17.87M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.33M | 2.58M | 1.66M | 1.88M | 2.14M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.67M | 2.58M | 2.58M | 2.58M | 3.31M |
| Total Liabilities | 27.33M | 25.99M | 22.18M | 22.15M | 23.32M |
|
|
|||||
| Common Stock & APIC | 237.44M | 232.20M | 228.01M | 223.47M | 221.69M |
| Retained Earnings | -173.24M | -176.85M | -181.91M | -189.09M | -190.97M |
| Treasury Stock & Other | -4.00K | -5.00K | -4.00K | -7.00K | -2.00K |
| Total Common Equity | 64.20M | 55.35M | 46.09M | 34.37M | 30.72M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 64.20M | 55.35M | 46.09M | 34.37M | 30.72M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 64.20M | 55.35M | 46.09M | 34.37M | 30.72M |
|
|
|||||